HomeInsightsStock Comparison

J B Chemicals Pharmaceuticals Ltd vs Zydus Lifesciences Ltd Stock Comparison

J B Chemicals Pharmaceuticals Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Jun 23, 2025

Key Highlights

  • The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1770 as of 23 Jun 11:01.
  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 26.31% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 2.37% over 5 years.
  • The Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25598 crore on March 2024 . This represents a CAGR of 45.48% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 101151 crore on March 2024 . This represents a CAGR of 29.90% over 5 years.
  • The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 5.97% .
  • The Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 34.99 % on March 2024 . This represents a CAGR of 1.99% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 8.77 % on March 2024 . This represents a CAGR of -19.14% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

News

J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/...

Read more

05 Jun 2025 12:59

News

Board of J B Chemicals & Pharmaceuticals recommends final dividend

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

15 May 2025 09:45

News

J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 202...

Read more

06 May 2025 09:12

News

J B Chemicals & Pharmaceuticals schedules board meeting

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

22 Apr 2025 17:20

News

JB Chemicals & Pharma receives USFDA approval for Bisoprolol Tablets

The approved product is the generic version of Zebeta (marketed by Teva Pharmaceuticals) a...

Read more

21 Apr 2025 09:57

Zydus Lifesciences Ltd News Hub

News

Zydus Life Matoda facility receives two observations from USFDA after inspection

In a regulatory filing, the company confirmed that the USFDA conducted a follow-up inspect...

Read more

19 Jun 2025 09:50

News

Zydus Lifesciences appoints Managing Director

Zydus Lifesciences has approved the appointment of s. Swati Dalal as the Additional Direct...

Read more

16 Jun 2025 14:16

News

Zydus Life subsidiary ZHL appoints Swati Dalal as MD

The appointment was approved by the nomination and remuneration committee (NRC). Swati Dal...

Read more

16 Jun 2025 14:42

News

Zydus Life receives USFDA EIR for Gujarat facility

The inspection was conducted by the USFDA from March 10 to March 14, 2025. Following the r...

Read more

12 Jun 2025 09:55

News

Zydus' Ankleshwar API unit clears USFDA inspection

Zydus Lifesciences has received the Establishment Inspection Report (EIR) report from the ...

Read more

12 Jun 2025 10:41

News

Zydus Lifesciences Ltd spurts 0.24%, up for fifth straight session

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at R...

Read more

10 Jun 2025 13:00

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, J B Chemicals & Pharmaceuticals Ltd or Zydus Lifesciences Ltd?

Market cap of J B Chemicals & Pharmaceuticals Ltd is 27,641 Cr while Market cap of Zydus Lifesciences Ltd is 96,296 Cr

What are the key factors driving the stock performance of J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

The stock performance of J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

As of June 23, 2025, the J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1771.25. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹957.0.

How do dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions